FDA to weigh easing limits on unproven peptides promoted by RFK Jr. BPC 157 Banned: Key Facts on the Latest FDA Decision Emerging Use of BPC 157 in Orthopaedic Sports Medicine: A Systematic Review Nikhil Vasireddi, Henrik Hahamyan, Michael J. Salata, Michael Karns, Jacob G. Calcei, James E. Voos, John M. Apostolakos, 2025 The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The wellness world is eager for RFK Jr.'s promised move on peptides : NPR The FDA is reviewing 12 peptides for removal from its restricted listincluding BPC 157, TB 500, Semax, and GHK Cu. If it goes through, it's the biggest peptide policy shift in years. More access. Easier